RISE – Chemical and Pharmaceutical Safety
| Reference number | |
| Coordinator | RISE Research Institutes of Sweden AB - Ytor, Process och Formulering, Stockholm |
| Funding from Vinnova | SEK 10 000 000 |
| Project duration | January 2019 - December 2022 |
| Status | Completed |
Purpose and goal
The long-term aim was to build up the activities in RISE - Chemical and pharmaceutical safety to secure a national infrastructure that can meet the needs of society, industry and academia for toxicological safety evaluations. Knowledge of the toxicological activities at RISE is now well established. RISE continuously carries out toxicological assignments and assessments at the request of national and international organizations and is also prepared to meet future needs.
Expected results and effects
The competence and experience of the infrastructure of Swetox/Gärtuna has been expanded and secured through the transition to RISE. All relevant parts of a GLP tox study are now gathered within RISE. The toxicological expertise has been connected with other expertise within RISE´s broad research infrastructure, eg biological and AI expertise, and researchers have jointly developed cell biological and computer-based predictive analysis methods intended for the market. The department Chemical and Pharmaceutical Safety are today a contracted partner in applied research.
Planned approach and implementation
At the beginning of the project (2019), the focus was on start-up/changeover, as well as building infrastructure. A move to modern and operationally adapted premises was planned in 2019, and carried out in 2020. The number of employees in the Chemical and Pharmaceutical Safety department has doubled during the project period. The last part of the project (2021-22) was more focused on method development, collaboration within and outside RISE and application work.